Cargando…

Blood Biomarkers in Cardioembolic Stroke

One promising field in neurovascular diseases investigation is the use of biomarkers to guide stroke etiology diagnosis and classification. Since treatment differs among etiologic subtypes and nowadays many patients receive a diagnosis of undetermined stroke, biomarkers might become an important add...

Descripción completa

Detalles Bibliográficos
Autores principales: García-Berrocoso, Teresa, Fernández-Cadenas, Israel, Delgado, Pilar, Rosell, Anna, Montaner, Joan
Formato: Texto
Lenguaje:English
Publicado: Bentham Science Publishers Ltd. 2010
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2994111/
https://www.ncbi.nlm.nih.gov/pubmed/21804778
http://dx.doi.org/10.2174/157340310791658767
_version_ 1782192885547925504
author García-Berrocoso, Teresa
Fernández-Cadenas, Israel
Delgado, Pilar
Rosell, Anna
Montaner, Joan
author_facet García-Berrocoso, Teresa
Fernández-Cadenas, Israel
Delgado, Pilar
Rosell, Anna
Montaner, Joan
author_sort García-Berrocoso, Teresa
collection PubMed
description One promising field in neurovascular diseases investigation is the use of biomarkers to guide stroke etiology diagnosis and classification. Since treatment differs among etiologic subtypes and nowadays many patients receive a diagnosis of undetermined stroke, biomarkers might become an important additional diagnostic tool. In this review we update current knowledge about biomarkers related with cardioembolic stroke etiology (such as BNP and D-dimer proteins, or PITX2 and ZFHX3 genes), that in the future, might allow rapidly guiding other diagnostic tests and accelerating the onset of an optimal secondary prevention.
format Text
id pubmed-2994111
institution National Center for Biotechnology Information
language English
publishDate 2010
publisher Bentham Science Publishers Ltd.
record_format MEDLINE/PubMed
spelling pubmed-29941112011-08-01 Blood Biomarkers in Cardioembolic Stroke García-Berrocoso, Teresa Fernández-Cadenas, Israel Delgado, Pilar Rosell, Anna Montaner, Joan Curr Cardiol Rev Article One promising field in neurovascular diseases investigation is the use of biomarkers to guide stroke etiology diagnosis and classification. Since treatment differs among etiologic subtypes and nowadays many patients receive a diagnosis of undetermined stroke, biomarkers might become an important additional diagnostic tool. In this review we update current knowledge about biomarkers related with cardioembolic stroke etiology (such as BNP and D-dimer proteins, or PITX2 and ZFHX3 genes), that in the future, might allow rapidly guiding other diagnostic tests and accelerating the onset of an optimal secondary prevention. Bentham Science Publishers Ltd. 2010-08 /pmc/articles/PMC2994111/ /pubmed/21804778 http://dx.doi.org/10.2174/157340310791658767 Text en © 2010 Bentham Science Publishers Ltd. http://creativecommons.org/licenses/by/2.5/ This is an open access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.5/), which permits unrestrictive use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Article
García-Berrocoso, Teresa
Fernández-Cadenas, Israel
Delgado, Pilar
Rosell, Anna
Montaner, Joan
Blood Biomarkers in Cardioembolic Stroke
title Blood Biomarkers in Cardioembolic Stroke
title_full Blood Biomarkers in Cardioembolic Stroke
title_fullStr Blood Biomarkers in Cardioembolic Stroke
title_full_unstemmed Blood Biomarkers in Cardioembolic Stroke
title_short Blood Biomarkers in Cardioembolic Stroke
title_sort blood biomarkers in cardioembolic stroke
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2994111/
https://www.ncbi.nlm.nih.gov/pubmed/21804778
http://dx.doi.org/10.2174/157340310791658767
work_keys_str_mv AT garciaberrocosoteresa bloodbiomarkersincardioembolicstroke
AT fernandezcadenasisrael bloodbiomarkersincardioembolicstroke
AT delgadopilar bloodbiomarkersincardioembolicstroke
AT rosellanna bloodbiomarkersincardioembolicstroke
AT montanerjoan bloodbiomarkersincardioembolicstroke